| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.57B | 25.44B | 15.53B | 15.11B | 12.18B | 10.85B |
| Gross Profit | 16.57B | 25.39B | 15.53B | 7.89B | 5.30B | 10.37B |
| EBITDA | 18.26B | 26.08B | 21.88B | 18.55B | 11.51B | 15.70B |
| Net Income | 5.02B | 4.50B | 4.15B | 3.35B | 3.92B | 3.27B |
Balance Sheet | ||||||
| Total Assets | 417.73B | 405.85B | 409.69B | 354.72B | 341.84B | 303.33B |
| Cash, Cash Equivalents and Short-Term Investments | 22.84B | 10.36B | 69.44B | 29.76B | 36.83B | 34.99B |
| Total Debt | 354.57B | 343.68B | 342.87B | 298.95B | 294.95B | 258.73B |
| Total Liabilities | 376.11B | 365.59B | 372.41B | 320.43B | 311.73B | 276.70B |
| Stockholders Equity | 41.62B | 40.26B | 37.28B | 34.28B | 30.11B | 26.63B |
Cash Flow | ||||||
| Free Cash Flow | -70.24B | -22.54B | 46.67B | 3.06B | -842.62M | 10.88B |
| Operating Cash Flow | -51.67B | 582.68M | 66.83B | 17.00B | 23.71B | 27.81B |
| Investing Cash Flow | -5.17B | -32.53B | -35.32B | -8.79B | -24.12B | -13.01B |
| Financing Cash Flow | 1.93B | -7.16B | -7.49B | -14.47B | -3.12B | 1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$6.84B | 5.14 | 5.14% | 11.28% | 0.59% | -5.95% | |
65 Neutral | HK$1.37B | 4.31 | 8.51% | 7.43% | 1.11% | 3.98% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | HK$270.55M | 20.00 | 1.09% | ― | 8.77% | -76.88% | |
56 Neutral | HK$18.71B | 2.09 | 12.27% | 5.84% | 3.17% | 23.13% | |
54 Neutral | HK$33.27B | 8.52 | 7.50% | 6.69% | -1.77% | -24.74% | |
42 Neutral | HK$119.80M | -1.47 | -29.10% | ― | 25.64% | -25.07% |